Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
thereby ameliorating muscle wasting in the hypermetabolic state of cancer cachexia
457961-34-1
Following DOT1L inhibition
InChi: InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6
Molecular Weight: 211
Tariquidar 60314 thereby ameliorating muscle wasting inTariquidar, also known as XR9576, is a P glycoprotein (P gp) inhibitor undergoing research as an adjuvant against multidrug resistance in cancer. Tariquidar non competitively binds to the p glycoprotein transporter, thereby inhibiting transmembrane transport of anticancer drugs. Inhibition of transmembrane transport may result in increased intracellular concentrations of an anticancer drug, thereby augmenting its cytotoxicity. Product information CAS
US$ 160.00
US$ 749.50
US$ 237.50
US$ 499.50
US$ 79.00
US$ 474.50
US$ 99.00
US$ 3515.00
US$ 200.00